SELL 70% MINIMUM AT MARKET; RETAIN 15-20% WITH HARD STOP AT $91.34

• Price is 7.75% below the 50-day SMA of $99.37, representing a structural trend break rather than marginal violation
• 200-day SMA at $86.28 is 6% below current prices with no support between
• ROE of 6.21% is below cost of equity of 9-10%, indicating economic value destruction
• 2.82% dividend yield does not compensate for tail risk given balance sheet concerns
• Total debt of $76.3B with $50.1B net debt and negative tangible book value of -$30.4B
• Intangibles plus goodwill of $110B represents 43% of total assets
• Mean reversion bounce probability to $94.67-$95.16 is only ~50% — a coin flip that conservative discipline should not bet on
• Fed hiked in September with Polymarket pricing 95% probability of zero cuts in 2026; 10-year pinned near 5%
• Higher-for-longer rates increase refinancing costs on $76.3B debt with $3B annual interest expense
• IRA drug pricing negotiations, PBM rebate reform, state pharmacy regulations, and MA reimbursement pressure represent accumulating structural headwinds
• Management's own guidance of 2027 headwinds should be taken as a warning, not reassurance
• Waiting for $94.67 exit risks selling into a falling market if bounce fails to materialize

→ vs aggressive: The 30-50% trim is too timid and still assumes the bounce materializes; the 50% bounce probability is a coin flip that capital preservation should not rely on; the proposal to keep a dividend core perpetuates exposure to a fundamentally challenged name with ROE below cost of capital

→ vs neutral: Hold position is indefensible at current levels given the structural trend breakdown, ROE of 6.21% below cost of equity, balance sheet with negative tangible book value, and 2.82% yield that does not compensate for the risk of capital impairment; waiting for confirmation risks further deterioration before acting

HOLD with staged trim: Sell 25% at market within 1-2 sessions, sell 25% via limit orders at $94.50-$95.50 (valid 10 trading sessions), retain 50% with hard stop at $86.28 and discretionary trim trigger at $91.34; consider covered call overlay on retained position; re-evaluate after Q3 earnings.

• Conservative's 70% sell at $91.72 is selling into oversold extreme (RSI 35.68, touching lower Bollinger Band), not capital preservation
• Dividend dismissal is flawed: 2.82% yield covered by $5.65B quarterly FCF is cash return on capital, not sentiment
• Balance sheet shows improvement: Net debt down $6.6B in 12 months, equity rose from $72.9B to $79.7B
• FCF trajectory improved from $0.1B in Q3 2025 to $5.65B in Q2 2026
• Conservative's stop at $91.34 is same level that historically marks exhaustion
• Aggressive is correct on direction but wrong on execution and timing
• 50% probability of mean reversion to $94.67 exists and cannot be ignored (RSI near 36, MACD histogram flipping positive)
• Aggressive's execution plan only works half the time when bounce materializes
• Covered call overlay (sell $95-$97 strike calls for Oct/Nov) can monetize elevated IV, improve cost basis by 1-2%
• Capital preservation includes right to wait; no need to be fully deployed or fully divested today

→ vs conservative: Selling 70% at market when price is touching lower Bollinger Band ($91.72) is panic, not risk management; RSI of 35.68 and intraday low of $91.44 suggest exhaustion, not regime change; the hard stop at $91.34 is the same level that historically marks bottom

→ vs aggressive: Pre-committed to bear thesis by dismissing 50% probability of mean reversion to $94.67; RSI near 36 with MACD histogram flipping positive is textbook mean-reversion setup; execution plan of selling into $94.67-$95.16 zone only works half the time, leaving full exposure when bounce fails